Literature DB >> 23155238

Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells.

Malgorzata Stec1, Jaroslaw Baran, Monika Baj-Krzyworzeka, Kazimierz Weglarczyk, Jolanta Gozdzik, Maciej Siedlar, Marek Zembala.   

Abstract

BACKGROUND: The chemokine-chemokine receptor (CR) network is involved in the regulation of cellular infiltration of tumours. Cancer cells and infiltrating macrophages produce a whole range of chemokines. This study explored the expression of some CR and chemokine production by cord blood stem cell-derived CD34(+) monocytes and their novel CD14(++)CD16(+) and CD14(+)CD16(-) subsets in response to tumour cells.
MATERIAL AND METHODS: CR expression was determined by flow cytometry and their functional activity by migration to chemoattractants. Monocytes were cultured with tumour cells and the chemokine content was assessed in culture supernatants.
RESULTS: CD14(++)CD16(+) monocytes exhibited increased expression of chemokine (C-C) receptor (CCR) 1, while CD14(+)CD16(-) of CCR2, chemokine (C-X-C) receptor (CXCR) 1, 2 and 4. The increased expression of CCR2 on CD14(+)CD16(-) monocytes was associated with their enhanced migration to monocyte chemoattractant protein-1 (CCL2), MCP-3 (CCL7), MCP-2 (CCL8) and MCP-4 (CCL13), while that of CXCR1 and 2 to interleukin 8 (CXCL8), and CXCR4 to stromal cell-derived factor-1 (CXCL12). Tumour cells induced production of macrophage inflammatory protein-1α (CCL3) MIP-1β and regulated on activation normal T-cells expressed and secreted (CCL5) but not CCL2 or CXCL8, monokine induced by gamma interferon (CXCL9), interferon gamma-induced protein 10 (CXCL10).
CONCLUSION: The studied monocyte subsets, in comparison to those from blood, exhibit different expression of CRs and response to the stimuli that occur from tumour cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23155238

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Xin Lou; Heli Gao; Xiaowu Xu; Zeng Ye; Wuhu Zhang; Fei Wang; Jie Chen; Yue Zhang; Xuemin Chen; Yi Qin; Xianjun Yu; Shunrong Ji
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

2.  Oxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytes.

Authors:  Johannes Rolin; Heidi Vego; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2014-09-23       Impact factor: 4.546

3.  PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.

Authors:  Wei-Ren Liu; Meng-Xin Tian; Liu-Xiao Yang; Yu-Li Lin; Lei Jin; Zhen-Bin Ding; Ying-Hao Shen; Yuan-Fei Peng; Dong-Mei Gao; Jian Zhou; Shuang-Jian Qiu; Zhi Dai; Rui He; Jia Fan; Ying-Hong Shi
Journal:  Oncotarget       Date:  2015-01-20

Review 4.  Implications of chemokine receptors and inflammatory lipids in cancer.

Authors:  Johannes Rolin; Azzam A Maghazachi
Journal:  Immunotargets Ther       Date:  2013-12-24

5.  The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma.

Authors:  Giovanni Luca Gravina; Andrea Mancini; Francesco Marampon; Alessandro Colapietro; Simona Delle Monache; Roberta Sferra; Flora Vitale; Peter J Richardson; Lee Patient; Stephen Burbidge; Claudio Festuccia
Journal:  J Hematol Oncol       Date:  2017-01-05       Impact factor: 17.388

6.  Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4.

Authors:  Lisa D Volk-Draper; Kelly L Hall; Andrew C Wilber; Sophia Ran
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

Review 7.  Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Stem Cell Res Ther       Date:  2015-10-07       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.